24 Participants Needed

FallScape for Falling Prevention

(FS-D Trial)

Age: 18+
Sex: Any
Trial Phase: Phase < 1
Sponsor: Brookside Research & Development Company
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

Trial Summary

What is the purpose of this trial?

Falls are a common and expensive problem, especially in persons with cognitive impairment due to Alzheimer's Disease and Related Dementias (PwADRD). The annual cost of falls is approximately 70 billion dollars, and falls add to the burden of a family caregiver. Injurious falls are a frequent reason people are unable to remain at home, resulting in significantly increased care costs to the family and society.Most falls prevention efforts fail to address the understanding of fall risks, or the need to change the behavior of the PwADRD, the caregiver, or both. In response to a National Institute on Aging request for 'Care technology to sustain in-home living, preserve function and promote effective communication', an innovative falls prevention intervention for use by caregivers of PwADRD who are still living at home and classified as at moderate to high risk for falls will be developed and tested. This new technology is called FallScape for Dementia (FS-D). The innovative caregiver-provided daily treatment uses an engaging multimedia approach and behavioral intervention methods to facilitate communication and encourage change in falls prevention behaviors to reduce PwADRD falls.This new FS-D intervention offers the rare opportunity to empower both the caregiver and the Person with memory loss by breaking the frustrating cycle of failure to recognize what could make an individual fall, or change behavior and may mitigate the burden that results from falls. FS-D is an urgently needed falls prevention intervention for family caregiver use. The economic and quality of life benefits of sustaining in-home living by preventing falls will benefit not only the caregiver and family, but will accrue to all stakeholders for this large, high-risk population.

Research Team

VP

Victoria Panzer, MA, EdM, PhD

Principal Investigator

Brookside Research & Development

Eligibility Criteria

This trial is for people with Alzheimer's or related dementias who are at moderate to high risk of falling and live at home. Caregivers will use a new technology called FallScape for Dementia (FS-D) designed to prevent falls by improving communication and changing behaviors.

Inclusion Criteria

I can walk at least six feet on my own or with help.
I have Alzheimer's or related dementia and have fallen at least twice last year or once with injury.
Caregivers must have access to a telephone
See 7 more

Exclusion Criteria

Caregivers cannot have cognitive impairment or dementia
Caregivers cannot have a terminal illness with survival less than 6 months
Caregivers cannot be professional caregivers
See 11 more

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Initial Visit and Pre-test

Initial visit includes informed consent, initial interview, and pre-test with video clips to assess fall threat awareness

1 day
1 visit (in-person)

Treatment

Daily multimedia sessions using FS-D intervention, with weekly electronic postcard submissions and weekly support calls

4 weeks
Daily sessions (virtual), weekly calls (virtual)

Follow-up

Follow-up interview and post-test with video clips to assess fall threat awareness, continued weekly postcard submissions and monthly calls

6 months
1 follow-up visit (in-person), monthly calls (virtual)

Treatment Details

Interventions

  • FallScape for Persons with Alzheimer's disease or a related Dementia (FS-D)
Trial Overview The intervention being tested is FallScape for Dementia (FS-D), an innovative multimedia tool aimed at caregivers of persons with dementia. It seeks to reduce the frequency of falls by enhancing understanding of fall risks and promoting preventive behavior changes.
Participant Groups
1Treatment groups
Experimental Treatment
Group I: FS-D InterventionExperimental Treatment1 Intervention
All dyads will receive the FS-D intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

Brookside Research & Development Company

Lead Sponsor

Trials
2
Recruited
120+

National Institute on Aging (NIA)

Collaborator

Trials
1,841
Recruited
28,150,000+
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security